GlassScriptPhysician profile
Teja Karukonda
NPI 1811308489
$104,968.77
in general payments reported to CMS, 2019-2025
44 companies · $8,002 in 2025
The $8,002 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $4,185 · 2021: $3,153 · 2022: $4,738 · 2023: $16K · 2024: $4,618 · 2025: $8,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $10K · Travel and Lodging: $6,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,803.00 |
| Food and Beverage | $10,242.09 |
| Travel and Lodging | $6,038.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $60,853.09 | 2019-2023 | Acp |
| Spineart USA INC | $19,283.64 | 2022-2025 | Perla C, Scarlet, Scarlet Al-T |
| Depuy Synthes Sales INC. | $7,958.71 | 2019-2025 | Fibergraft Aeridyan Matrix, Teligen, Symphony |
| Globus Medical, INC. | $4,160.13 | 2019-2024 | Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System, A/R Femoral Nail |
| Xtant Medical INC | $4,113.76 | 2024-2025 | |
| Si-Bone, INC. | $1,778.75 | 2020-2024 | |
| Medical Device Business Services, INC. | $1,049.87 | 2019 | |
| Stryker Corporation | $694.45 | 2019-2024 | Gamma, Axsos |
| Carestream Health, INC. | $565.00 | 2021-2022 | |
| Medtronic, INC. | $478.90 | 2021-2022 | |
| Becton, Dickinson and Company | $465.00 | 2023 | |
| Dr.Reddy'S Laboratories,INC. | $458.00 | 2023 | |
| Medtronic USA, INC. | $454.78 | 2019 | |
| Ossdsign USA Incorporated | $439.43 | 2023-2025 | Ossdsign Catalyst |
| Providence Medical Technology, INC. | $365.66 | 2022-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $294.40 | 2023-2024 | Invictus Mis, Osseoscrew, Other - Miscellaneous |
| Intrinsic Therapeutics | $267.98 | 2022 | |
| Seapearl East, INC | $214.16 | 2022-2024 | |
| Orthofix Medical, INC. | $171.79 | 2022-2025 | Physio-Stim |
| Nevro Corp. | $147.17 | 2021 | |
| Carlsmed, INC. | $104.46 | 2022 | |
| Augmedics INC. | $82.04 | 2022-2025 | Xvision |
| Zimmer Biomet Holdings, INC. | $66.27 | 2023 | Stratum Foot Plating System |
| Integrity Implants INC. | $64.71 | 2022 | |
| Abbott Laboratories | $50.88 | 2021-2024 | Eterna, Proclaim |
| Pacira Pharmaceuticals Incorporated | $45.74 | 2020-2025 | Exparel |
| Terumo Bct, INC. | $37.38 | 2021 | |
| Heron Therapeutics, INC. | $31.95 | 2022-2023 | Zynrelef |
| Kuros Biosciences USA, INC | $31.17 | 2025 | Magnetos |
| Misonix INC | $25.53 | 2021 | |
| Linkbio Corp | $23.42 | 2025 | |
| Treace Medical Concepts, INC. | $21.68 | 2022 | |
| Ethicon US, LLC | $21.36 | 2020 | |
| Integra Lifesciences Corporation | $19.64 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.42 | 2025 | Relistor |
| Averitas Pharma INC. | $14.28 | 2023 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $13.84 | 2022 | |
| Ibsa Pharma INC. | $13.28 | 2023 | Tirosint, Licart |
| Trevena, INC. | $12.69 | 2022 | |
| Paragon 28, INC. | $12.62 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.06 | 2021 | |
| Zimvie INC. | $11.94 | 2022 | |
| Bioventus LLC | $11.57 | 2021 | |
| Horizon Therapeutics Plc | $11.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teja Karukonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.